Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Accumulated Expenses (2017 - 2026)

Neuronetics has reported Accumulated Expenses over the past 10 years, most recently at $174000.0 for Q1 2026.

  • Quarterly Accumulated Expenses rose 0.58% to $174000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $174000.0 through Mar 2026, up 0.58% year-over-year, with the annual reading at $179000.0 for FY2025, 22.84% down from the prior year.
  • Accumulated Expenses was $174000.0 for Q1 2026 at Neuronetics, down from $179000.0 in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $11.4 million in Q3 2024 and troughed at $169000.0 in Q3 2025.
  • The 5-year median for Accumulated Expenses is $255000.0 (2024), against an average of $3.2 million.
  • Year-over-year, Accumulated Expenses surged 2574.0% in 2022 and then crashed 98.52% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $11.2 million in 2022, then tumbled by 98.1% to $213000.0 in 2023, then rose by 8.92% to $232000.0 in 2024, then fell by 22.84% to $179000.0 in 2025, then fell by 2.79% to $174000.0 in 2026.
  • Per Business Quant, the three most recent readings for STIM's Accumulated Expenses are $174000.0 (Q1 2026), $179000.0 (Q4 2025), and $169000.0 (Q3 2025).